Form D · Biotechnology
BioDtech Inc
Birmingham, AL · CIK 0001316122
Offering snapshot reported Aug 25, 2010 · SEC filing
- Reported sold
- $575K Offering amount: $750K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Aug 11, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 25, 2010 | Initial | $575,000 | No comparison | 6 | SEC filing |
| Jan 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-146896
Source: Form D, filed Aug 25, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Dean | Director |
| Michael G. Pepe | Director, Executive |
| Ira Weiss | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2100 South Bridge Pkwy Suite 650
Birmingham, AL, 35209
Birmingham, AL, 35209